International Clinical Trial: Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07298473) titled 'Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)' on Dec. 19, 2025.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Medtronic Cardiac Ablation Solutions

Condition: Atrial Fibrillation (AF) Persistent Atrial Fibrillation Paroxysmal Atrial Fibrillation (PAF)

Intervention: Device: Sphere-9 Catheter Ablation

Recruitment Status: Not recruiting

Phase: N/A

Date o...